
How AI Can Shape The Future Of Clinical Documentation Improvement
Clinical documentation is the written record of a patient-physician encounter.
Before the advent of electronic health records (EHRs), these encounters were often inadequately documented. While this allowed for faster visits and more personal interaction between doctor and patient, it created several issues.
Without a written record, follow-up visits lacked context, making continuity of care more difficult. In cases requiring multidisciplinary input, providers had no shared documentation to review, limiting collaboration and informed decision-making. The absence of structured records also made it difficult for healthcare systems to monitor or assess care quality.
Insurance companies and hospital administrators, too, lacked insight into the care being provided. This lack of transparency made assessing performance, ensuring compliance or justifying reimbursement challenging. Documentation, or the lack thereof, became a silent barrier to systemic efficiency and accountability.
Today, comprehensive and timely clinical documentation is not just preferred, it's essential. It is a cornerstone for care coordination, patient safety, quality reporting and reimbursement. As expectations grow, so too does the pressure on clinicians to document thoroughly, accurately and efficiently.
Clinical documentation has evolved immensely since EHRs were introduced in the 1990s, and the next major evolution is the introduction of AI. Let's look at how AI will impact how clinical interactions are recorded.
The Role Of Clinical Documentation Improvement (CDI)
Clinical documentation improvement (CDI) ensures that medical records are complete, accurate and clinically meaningful. It captures the complete picture of a patient's condition, the care delivered and the outcomes achieved.
The key benefits of CDI include:
• Better Patient Care: Comprehensive records enable clinicians to make informed decisions based on a clear understanding of patient history and treatment.
• Regulatory Compliance: Accurate, rule-aligned documentation supports billing and legal standards compliance.
• Fair Reimbursement: When documentation reflects the complexity of care, providers are more likely to be compensated appropriately.
• Improved Data Use: High-quality documentation supports analytics, planning and population health management.
Current State Of CDI
Today, CDI is essentially a manual and retrospective process. Specialists review a subset of medical records after the visit has occurred. If documentation is incomplete or ambiguous, they send queries to the provider, often days or weeks later, when recall may be limited. Due to staffing constraints, only a fraction of cases are reviewed, leaving many gaps unaddressed.
Although widely recognized as essential, CDI is not yet fully integrated into clinical workflows. Rather than easing the administrative burden, it often adds to it. For CDI to achieve its potential, it must become real-time and seamlessly embedded into the care process.
Without CDI, for example, a provider might document only "diabetes." This leads to a generic code that doesn't reflect all aspects of the patient's condition, including any complications from diabetes. With CDI support, the physician is prompted to include "diabetic nephropathy," allowing accurate assignment of a Hierarchical Condition Category (HCC) code and ensuring appropriate reimbursement and clinical clarity.
The Historical Evolution Of AI In Clinical Documentation
Until the early 2010s, most hospitals relied on paper records. With the adoption of EHRs, the shift to digital documentation opened the door to innovation. Early efforts focused on rule-based systems that searched for predefined terms in provider notes. However, these notes are often unstructured and lengthy, limiting the scalability of such systems.
The emergence of machine learning and natural language processing (NLP) changed the landscape. Models, including gradient boosted decision trees and large language models (LLMs), have made it possible to interpret and analyze vast amounts of clinical text. This enabled the development of more innovative CDI tools to improve accuracy across diverse clinical scenarios.
According to the 2024 Association of Clinical Documentation Integrity Specialists (ACDIS) survey, 56.58% of respondents (download required) reported that technology has helped identify straightforward documentation gaps, freeing up CDI teams to focus on more complex cases—an increase from 49.37% in 2023.
AI's Potential Role In Improving CDI
AI is particularly well-suited for reading and interpreting complex clinical narratives. It can process unstructured data at scale and offer real-time support to providers. For instance, AI-powered tools can:
• Identify missing or ambiguous information during or immediately after a clinical encounter.
• Transcribe and organize spoken interactions between patients and clinicians.
• Recommend accurate diagnoses and codes based on current and historical data.
• Simplify technical language to support better patient understanding.
Looking ahead, AI tools will not only flag deficiencies—they will proactively surface likely conditions, suggest evidence-based coding and highlight potential compliance risks. Over time, these tools will be able to adapt to individual documentation styles to offer personalized support.
Challenges With The AI Model
Despite their promise, AI models—particularly LLMs—pose notable challenges in clinical settings. Their probabilistic nature means they may generate different outputs for the same input, which is incompatible with the deterministic standards of clinical care. Accuracy, reproducibility and traceability are essential when patient safety is at stake.
One persistent issue is hallucinations, where the AI fabricates information that may seem plausible but is factually incorrect. While cleaning training data and applying rule-based constraints have helped reduce these errors, they do not eliminate them. Incorporating human oversight can further mitigate risk but introduces additional workflow complexity.
LLMs also lack transparency. Their black-box architecture makes auditing claims or explaining specific outputs difficult, raising concerns during clinical reviews or regulatory scrutiny. Although models like gradient boosting machines (GBMs) offer more interpretability and consistency, they struggle to capture nuanced relationships in unstructured medical text.
Conclusion
AI has the potential to transform clinical documentation from a tedious task into a strategic enabler of quality care. By synthesizing complex narratives and offering real-time, intelligent support, technologies like LLMs and GBMs can help clinicians document more accurately and efficiently.
However, this transformation must be approached with care. Ensuring clinical accuracy, protecting patient privacy and maintaining provider trust are essential.
With thoughtful integration, rigorous validation and ongoing human oversight, AI-powered clinical documentation improvement can enhance—not replace—clinical judgment, paving the way for a future where technology supports care without compromising its integrity.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
2 days ago
- Forbes
How AI Can Shape The Future Of Clinical Documentation Improvement
Sameer Ather, MD, PhD, Co-Founder & CEO of XpertDox, leveraging AI to enhance medical coding efficiency and healthcare productivity. Clinical documentation is the written record of a patient-physician encounter. Before the advent of electronic health records (EHRs), these encounters were often inadequately documented. While this allowed for faster visits and more personal interaction between doctor and patient, it created several issues. Without a written record, follow-up visits lacked context, making continuity of care more difficult. In cases requiring multidisciplinary input, providers had no shared documentation to review, limiting collaboration and informed decision-making. The absence of structured records also made it difficult for healthcare systems to monitor or assess care quality. Insurance companies and hospital administrators, too, lacked insight into the care being provided. This lack of transparency made assessing performance, ensuring compliance or justifying reimbursement challenging. Documentation, or the lack thereof, became a silent barrier to systemic efficiency and accountability. Today, comprehensive and timely clinical documentation is not just preferred, it's essential. It is a cornerstone for care coordination, patient safety, quality reporting and reimbursement. As expectations grow, so too does the pressure on clinicians to document thoroughly, accurately and efficiently. Clinical documentation has evolved immensely since EHRs were introduced in the 1990s, and the next major evolution is the introduction of AI. Let's look at how AI will impact how clinical interactions are recorded. The Role Of Clinical Documentation Improvement (CDI) Clinical documentation improvement (CDI) ensures that medical records are complete, accurate and clinically meaningful. It captures the complete picture of a patient's condition, the care delivered and the outcomes achieved. The key benefits of CDI include: • Better Patient Care: Comprehensive records enable clinicians to make informed decisions based on a clear understanding of patient history and treatment. • Regulatory Compliance: Accurate, rule-aligned documentation supports billing and legal standards compliance. • Fair Reimbursement: When documentation reflects the complexity of care, providers are more likely to be compensated appropriately. • Improved Data Use: High-quality documentation supports analytics, planning and population health management. Current State Of CDI Today, CDI is essentially a manual and retrospective process. Specialists review a subset of medical records after the visit has occurred. If documentation is incomplete or ambiguous, they send queries to the provider, often days or weeks later, when recall may be limited. Due to staffing constraints, only a fraction of cases are reviewed, leaving many gaps unaddressed. Although widely recognized as essential, CDI is not yet fully integrated into clinical workflows. Rather than easing the administrative burden, it often adds to it. For CDI to achieve its potential, it must become real-time and seamlessly embedded into the care process. Without CDI, for example, a provider might document only "diabetes." This leads to a generic code that doesn't reflect all aspects of the patient's condition, including any complications from diabetes. With CDI support, the physician is prompted to include "diabetic nephropathy," allowing accurate assignment of a Hierarchical Condition Category (HCC) code and ensuring appropriate reimbursement and clinical clarity. The Historical Evolution Of AI In Clinical Documentation Until the early 2010s, most hospitals relied on paper records. With the adoption of EHRs, the shift to digital documentation opened the door to innovation. Early efforts focused on rule-based systems that searched for predefined terms in provider notes. However, these notes are often unstructured and lengthy, limiting the scalability of such systems. The emergence of machine learning and natural language processing (NLP) changed the landscape. Models, including gradient boosted decision trees and large language models (LLMs), have made it possible to interpret and analyze vast amounts of clinical text. This enabled the development of more innovative CDI tools to improve accuracy across diverse clinical scenarios. According to the 2024 Association of Clinical Documentation Integrity Specialists (ACDIS) survey, 56.58% of respondents (download required) reported that technology has helped identify straightforward documentation gaps, freeing up CDI teams to focus on more complex cases—an increase from 49.37% in 2023. AI's Potential Role In Improving CDI AI is particularly well-suited for reading and interpreting complex clinical narratives. It can process unstructured data at scale and offer real-time support to providers. For instance, AI-powered tools can: • Identify missing or ambiguous information during or immediately after a clinical encounter. • Transcribe and organize spoken interactions between patients and clinicians. • Recommend accurate diagnoses and codes based on current and historical data. • Simplify technical language to support better patient understanding. Looking ahead, AI tools will not only flag deficiencies—they will proactively surface likely conditions, suggest evidence-based coding and highlight potential compliance risks. Over time, these tools will be able to adapt to individual documentation styles to offer personalized support. Challenges With The AI Model Despite their promise, AI models—particularly LLMs—pose notable challenges in clinical settings. Their probabilistic nature means they may generate different outputs for the same input, which is incompatible with the deterministic standards of clinical care. Accuracy, reproducibility and traceability are essential when patient safety is at stake. One persistent issue is hallucinations, where the AI fabricates information that may seem plausible but is factually incorrect. While cleaning training data and applying rule-based constraints have helped reduce these errors, they do not eliminate them. Incorporating human oversight can further mitigate risk but introduces additional workflow complexity. LLMs also lack transparency. Their black-box architecture makes auditing claims or explaining specific outputs difficult, raising concerns during clinical reviews or regulatory scrutiny. Although models like gradient boosting machines (GBMs) offer more interpretability and consistency, they struggle to capture nuanced relationships in unstructured medical text. Conclusion AI has the potential to transform clinical documentation from a tedious task into a strategic enabler of quality care. By synthesizing complex narratives and offering real-time, intelligent support, technologies like LLMs and GBMs can help clinicians document more accurately and efficiently. However, this transformation must be approached with care. Ensuring clinical accuracy, protecting patient privacy and maintaining provider trust are essential. With thoughtful integration, rigorous validation and ongoing human oversight, AI-powered clinical documentation improvement can enhance—not replace—clinical judgment, paving the way for a future where technology supports care without compromising its integrity. Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?


Business Wire
04-08-2025
- Business Wire
Concord Technologies To Highlight Strategic Interoperability Solutions at DirectTrust Conference
SEATTLE--(BUSINESS WIRE)--Concord Technologies ('Concord'), a leader in Secure Document Exchange, Intelligent Document Processing, and Interoperability solutions, will return as a sponsor at the DirectTrust Annual Conference, Aug 4-7, in St. Louis. This event brings together the industry's brightest minds and thought leaders focused on solving healthcare's interoperability challenges. As a DirectTrust member since 2023, Concord is committed to advancing secure, standards-based information exchange across the healthcare ecosystem. The event's theme, The Intersection of Interoperability, Identity, and Cybersecurity, aligns with Concord's mission to solve healthcare's interoperability challenge with Straight-Through Processing —the receiving, processing, and integrating of documents and data directly into EHRs or other systems of record with minimal human intervention. 'Healthcare CIOs are under increasing pressure to unify fragmented systems and ensure secure, compliant data exchange,' said Chris Larkin, Concord's Chief Technology Officer. 'At DirectTrust we're excited to share Concord's multimodality approach to secure document exchange. Tools like Digital Fax, Secure File Transfer and, coming this fall, Direct Secure Messaging, or DSM, within our Concord Connect™ suite empower organizations to ingest and route structured and unstructured data seamlessly into downstream workflows. These capabilities are cornerstones in our commitment to helping healthcare organizations streamline the sharing and processing of healthcare data and achieve Straight-Through Processing.' Concord's solutions are engineered to meet the evolving needs of highly regulated healthcare organizations by integrating advanced security safeguards and AI-powered document processing. These capabilities allow sensitive patient data not only to be exchanged securely but also to be processed automatically, dramatically increasing the productivity of administrative teams, reducing costs, and supporting the delivery of care. Larkin will join the event's closing panel, Bringing It Together: The Intersection of Interoperability, Identity & Cybersecurity, at 10:45 a.m. on Aug. 7, where he will share insights on how the company is helping health systems achieve operational resilience and data integrity. He will join Kathryn Ayers Wickenhauser, Chief Strategy Officer, DirectTrust; Mike Green, Chief Information Security Officer, Availity; and Laura Nixon, VP, Interoperability Solutions, Clinical Architecture. These key voices will reflect on the conference's major themes — interoperability, identity, and cybersecurity — and share forward-looking insights on the future of trusted data exchange in healthcare. 'As data is received, integrated, and deployed into patient care and other workflows, we also make sure that our safeguards continue to protect that most valuable asset,' Larkin said. 'We are eager to share our insights along with our fellow panelists and attendees.' About Concord Technologies Concord Technologies is a leading provider of Secure Document Exchange, Intelligent Document Processing, and Interoperability solutions to healthcare providers, payers, and other highly regulated businesses. For more than 20 years, billions of sensitive records containing valuable patient information have been reliably, accurately, and securely sent and received across Concord's digital health network, and today, the company processes more than 4 billion pages of protected data each year. The company is also recognized for its best-in-class development of new artificial intelligence technologies, including Concord's Practical AI™ approach to solving the most pervasive administrative challenges in the healthcare industry and for its industry-leading applications that help its customers grow and manage their business. About DirectTrust DirectTrust is a non-profit healthcare industry alliance created to support secure, identity-verified electronic exchanges of protected health information (PHI) between provider organizations, as well as between providers and patients. This allows for improved care efficiency and coordination, transitions of care, patient satisfaction and helps reduce healthcare costs. DirectTrust also includes standards-development activities, more than 20 accreditation programs, and other services related to healthcare and identity that further develop trust.


Business Wire
14-07-2025
- Business Wire
Scipher and Savant Bio Partner to Build the Most Comprehensive Clinico-Genomic Dataset in Rheumatoid Arthritis
NEW YORK & WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a leader in precision immunology, and Savant Bio, a Roivant-backed health data infrastructure company, today announced an expanded strategic partnership to build the world's most advanced clinicogenomic dataset in rheumatoid arthritis (RA). The collaboration aims to generate high-resolution insights to support academic research, clinical trial design, therapeutic strategy, and real-world evidence generation. The collaboration centers on transforming real-world data from the electronic health records (EHRs) of patients tested with Scipher's clinically validated molecular signature test that predicts non-response to TNF inhibitor therapies, PrismRA ®. These data will be converted into structured, analysis-ready formats. By integrating deep genomic insights with comprehensive clinical context, the partnership aims to generate actionable real-world evidence to accelerate drug development in RA and related autoimmune conditions. 'Enormous potential is locked inside real-world clinical data, but much of it lives in an unstructured form,' said Brian Moriarty, Co-Founder of Savant Bio. 'By linking Scipher's validated genomic insights with structured patient journeys, we are creating the foundation for the next generation of real-world evidence to enable faster studies, richer evidence, and more targeted therapies in RA.' Savant's platform uses large language models (LLMs), paired with domain-specific quality controls, to extract structured variables from free-text clinical documentation, such as physician notes and pathology reports. Key enriched dimensions include biologic sequencing, disease activity scores (e.g., CDAI, DAS28), steroid exposure, radiographic findings, and treatment durability. Each output undergoes rigorous review to ensure accuracy and consistency and can be linked to claims, labs, and prescribing data for longitudinal analysis. 'As the leader in autoimmune transcriptomic data, we've long believed that combining molecular precision with real-world outcomes is key to advancing drug development in autoimmune disease,' said Reg Seeto, CEO of Scipher Medicine. 'By integrating structured clinical data through Savant's platform, we aim to enhance the utility of the growing Scipher dataset for applications ranging from trial design to market access — and ultimately support more personalized, evidence-driven treatment strategies in autoimmune diseases.' Initial structuring is underway on a cohort of more than 6,000 PrismRA-tested patients, creating one of the most comprehensive genomically defined RA cohorts with structured EHR data. Additional expansion is planned. The dataset will support critical use cases, including: Validating real-world predictors of treatment response Mapping treatment sequencing and disease control Building precision cohorts for post-TNFi trials Supporting post-market studies and label expansion The enriched dataset will be made available through collaborative research initiatives, co-publications, and structured licensing partnerships. Interested organizations are encouraged to engage early to help shape use cases and gain preliminary access to insights. About Scipher Medicine Scipher Medicine is redefining drug development in autoimmune diseases through its precision diagnostics platform, real-world data, and network biology. The company's Prism ® platform uses genomic signatures to guide therapeutic selection and generate insights into treatment response. Scipher has built the largest genomic biobank in RA, which is coupled with access to EHR data from a network of over 3 million rheumatology patients. Learn more at About Savant Bio Savant is transforming how healthcare and life sciences organizations unlock the value trapped in unstructured medical data. Its data abstraction platform combines advanced large language models with domain-specific quality controls to convert free-text clinical records into structured, analysis-ready data — efficiently, accurately, and at scale. Backed by Roivant, Savant partners with leading institutions across healthcare, life sciences, and research to deliver sharper insights and better outcomes. Learn more at